ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 274,48
-0,27%
Dow Jones
42 840,26
1,18%
DAX
19 884,75
-0,57%
Brent Oil
72,72
0,00%
Bitcoin
97 172,47
-0,04%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSXV

  6. Acasti Pharma Inc (ACST) Cours

Acasti Pharma Inc

Acasti Pharma Inc (ACST)

Acasti Pharma Inc
0,58
0,00
(0,00%)
Fermé 22 Décembre 10:00PM
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
0,58
Prix Achat
0,58
Prix Vente
0,98
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Cap du marché
5,451M
Clôture Veille
0,58
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
-
Actions en circulation
9 399 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-2,46
Bénéfice par action (BPA)
-1,37
Chiffre d'affairess
-
Bénéfice net
-12,85M

À propos de Acasti Pharma Inc

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.acastipharma.com
Siège social
Jersey City, New Jersey, USA
Fondé
-
Acasti Pharma Inc est coté dans le secteur Pharmaceutical Preparations de la TSX Venture Exchange avec le ticker ACST. Le dernier cours de clôture d'Acasti Pharma était de $0,58. Au cours de la dernière année, les actions de Acasti Pharma ont été négociées dans une fourchette de prix de $ 0,00 à $ 0,00.

Acasti Pharma compte actuellement 9 399 000 actions en circulation. La capitalisation boursière d'Acasti Pharma est de $5,45 million. Acasti Pharma a un ratio cours/bénéfice (ratio PE) de -2.46.

ACST Dernières nouvelles

Plus de nouvelles

Acasti Pharma Reports Third Quarter 2023 Operational Results

Company to Host Conference Call Today at 1:00pm ET LAVAL, Québec, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a...

14 Février 2023
GlobeNewswire Inc.

Acasti Receives Extension to Regain Compliance with NASDAQ Minimum Bid Price Rule

LAVAL, Québec, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

25 Janvier 2023
GlobeNewswire Inc.

Acasti Pharma to Present at Lytham Partners Investor Select Conference on January 31

LAVAL, Québec, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

24 Janvier 2023
GlobeNewswire Inc.

Acasti Pharma to Present at Sidoti Virtual Investor Conference on January 18

LAVAL, Québec, Jan. 13, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

13 Janvier 2023
GlobeNewswire Inc.

Acasti to Host Conference Call on Tuesday, January 10, 2023 to Discuss Results from Recent Phase 1 PK Studies for GTX-101 and GTX-102 That Met All Outcome Measures

LAVAL, Québec, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

05 Janvier 2023
GlobeNewswire Inc.

Acasti Announces Preliminary Topline Results Met All Outcome Measures in the Pharmacokinetic Bridging Study for GTX-102, the Company’s Drug Candidate for the Treatment of Ataxia Telangiectasia

LAVAL, Québec, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

28 Décembre 2022
GlobeNewswire Inc.

Acasti Pharma Announces Preliminary Topline Results Met All Primary Outcome Measures in the Single Dose Pharmacokinetic Study for GTX-101, the Company’s Drug Candidate for the Treatment of Postherpetic Neuralgia (PHN)

LAVAL, Québec, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

22 Décembre 2022
GlobeNewswire Inc.

Acasti Pharma Reports Second Quarter 2023 Operational Results

Company to Host Conference Call Today at 1:00pm ET LAVAL, Québec, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a...

14 Novembre 2022
GlobeNewswire Inc.

Acasti Pharma to Present at Q4 Investor Summit

LAVAL, Québec, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

09 Novembre 2022
GlobeNewswire Inc.

Acasti Pharma to Report Second Quarter 2023 Financial Results on Monday, November 14, 2022

LAVAL, Quebec, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three clinical...

07 Novembre 2022
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ACST - Frequently Asked Questions (FAQ)

What is the current Acasti Pharma share price?
The current share price of Acasti Pharma is $ 0,58
How many Acasti Pharma shares are in issue?
Acasti Pharma has 9 399 000 shares in issue
What is the market cap of Acasti Pharma?
The market capitalisation of Acasti Pharma is CAD 5,45M
What is the 1 year trading range for Acasti Pharma share price?
Acasti Pharma has traded in the range of $ 0,00 to $ 0,00 during the past year
What is the PE ratio of Acasti Pharma?
The price to earnings ratio of Acasti Pharma is -2,46
What is the reporting currency for Acasti Pharma?
Acasti Pharma reports financial results in USD
What is the latest annual profit for Acasti Pharma?
The latest annual profit of Acasti Pharma is USD -12,85M
What is the registered address of Acasti Pharma?
The registered address for Acasti Pharma is 103 CARNEGIE CENTER, SUITE 300 PRINCETON, JERSEY CITY, NEW JERSEY, 08540
What is the Acasti Pharma website address?
The website address for Acasti Pharma is www.acastipharma.com
Which industry sector does Acasti Pharma operate in?
Acasti Pharma operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
GNFIGenifi Inc
$ 0,015
(200,00%)
4k
GHR.HGolden Harp Resources Inc
$ 0,10
(185,71%)
2,73k
TVC.HThree Valley Copper Corp
$ 0,01
(100,00%)
2k
NICKNickelex Resource Corporation
$ 0,01
(100,00%)
1,1k
GAR.HGreen Arrow Resources Inc
$ 0,045
(80,00%)
1 000
CBAChampion Bear Resources Ltd
$ 0,015
(-62,50%)
101k
NIKL.HGK Resources LTD
$ 0,045
(-50,00%)
1 000
DMDataMetrex AI Limited
$ 0,005
(-50,00%)
3,34M
WWTWater Ways Technologies Inc
$ 0,005
(-50,00%)
106,09k
COOOstrom Climate Solutions Inc
$ 0,05
(-50,00%)
109,5k
QNCQuantum Emotion Corp
$ 0,435
(26,09%)
7,32M
GXUGoviEx Uranium Inc
$ 0,055
(10,00%)
4,68M
FUUF3 Uranium Corp
$ 0,25
(6,38%)
3,64M
AUUAALUULA Composites Inc
$ 0,05
(0,00%)
3,63M
DMDataMetrex AI Limited
$ 0,005
(-50,00%)
3,34M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

TSXV
ACST
Acasti Pharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés